Results 131 to 140 of about 6,040 (212)

Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use. [PDF]

Biomed Pharmacother
Paloczi J, Gunduz-Cinar O, Yokus B, Paes-Leme B, Haskó G, Kunos G, Holmes A, Pacher P.   +7 more
europepmc   +1 more source

<i>Cannabis</i> Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. [PDF]

Nanomaterials (Basel)
Żółnowska I, Gostyńska-Stawna A, Jelińska A, Stawny M.   +3 more
europepmc   +1 more source

Assessment of Abuse Potential of Three Indazole-Carboxamide Synthetic Cannabinoids 5F-ADB, MDMB-4en-PINACA and ADB-4en-PINACA. [PDF]

Int J Mol Sci
Qiao Y, Shi X, Li K, Kuai L, Li X, Di B, Xu P.   +6 more
europepmc   +1 more source

Sigara Bırakmada Farmakoterapi

Turkish Journal of Family Practice, 2006
Y. Hakan Doğan, Serdar Demirgören
doaj  

Synthesis and Pharmacological Characterization of Novel Peripheral Cannabinoid-1 Receptor Blockers Based on a Tricyclic Scaffold. [PDF]

J Med Chem
Gammal A, Nassar T, Soae Y, Freeman N, Badihi A, Baraghithy S, Nemirovski A, Tam J, Benita S.   +8 more
europepmc   +1 more source

Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation. [PDF]

J Cannabis Res
Portillo R, Synova T, Ghaddar MR, Alsouki MS, Kumnova F, Machacek M, Karahoda R, Abad C, Staud F.   +8 more
europepmc   +1 more source

Rimonabant

Drugs in R & D, 2002
openaire   +2 more sources

BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation. [PDF]

Molecules
Kim S, Dania AJ, Lim S, Choi J.
europepmc   +1 more source

Dorsomedial Striatum (DMS) CB1R Signaling Promotes Pavlovian Devaluation Sensitivity in Male Long Evans Rats and Reduces DMS Inhibitory Synaptic Transmission in Both Sexes. [PDF]

eNeuro
Stapf CA, Keefer SE, McInerney JM, Cheer JF, Calu DJ.   +4 more
europepmc   +1 more source

Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders. [PDF]

Front Pharmacol
Lackovic J, Dey S, Ward SJ, Greig NH, Tweedie D, Beiranvand N, Saini U, Chatterjee D, Varadhachary A.   +8 more
europepmc   +1 more source